CA1310159C - Membrane de fibres creuses de polypropylene poreux, methode pour sa production et son utilisation dans des poumons artificiels - Google Patents
Membrane de fibres creuses de polypropylene poreux, methode pour sa production et son utilisation dans des poumons artificielsInfo
- Publication number
- CA1310159C CA1310159C CA000556829A CA556829A CA1310159C CA 1310159 C CA1310159 C CA 1310159C CA 000556829 A CA000556829 A CA 000556829A CA 556829 A CA556829 A CA 556829A CA 1310159 C CA1310159 C CA 1310159C
- Authority
- CA
- Canada
- Prior art keywords
- hollow fiber
- fiber membrane
- polypropylene
- range
- artificial lung
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 239000012528 membrane Substances 0.000 title claims abstract description 229
- 239000012510 hollow fiber Substances 0.000 title claims abstract description 224
- -1 polypropylene Polymers 0.000 title claims abstract description 174
- 229920001155 polypropylene Polymers 0.000 title claims abstract description 171
- 239000004743 Polypropylene Substances 0.000 title claims abstract description 170
- 210000004072 lung Anatomy 0.000 title claims abstract description 80
- 238000004519 manufacturing process Methods 0.000 title claims description 25
- 210000004369 blood Anatomy 0.000 claims abstract description 65
- 239000008280 blood Substances 0.000 claims abstract description 65
- 239000002245 particle Substances 0.000 claims abstract description 38
- 239000011148 porous material Substances 0.000 claims abstract description 37
- 239000000835 fiber Substances 0.000 claims abstract description 36
- 210000002381 plasma Anatomy 0.000 claims abstract description 28
- 239000007790 solid phase Substances 0.000 claims abstract description 28
- 208000027418 Wounds and injury Diseases 0.000 claims abstract description 12
- 210000000601 blood cell Anatomy 0.000 claims abstract description 12
- 230000006378 damage Effects 0.000 claims abstract description 11
- 239000012071 phase Substances 0.000 claims abstract description 11
- 208000014674 injury Diseases 0.000 claims abstract description 10
- 238000001816 cooling Methods 0.000 claims description 69
- 239000007788 liquid Substances 0.000 claims description 51
- 239000012766 organic filler Substances 0.000 claims description 50
- 239000007789 gas Substances 0.000 claims description 45
- 238000000034 method Methods 0.000 claims description 42
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims description 23
- 239000001301 oxygen Substances 0.000 claims description 23
- 229910052760 oxygen Inorganic materials 0.000 claims description 23
- 239000003795 chemical substances by application Substances 0.000 claims description 20
- MYMOFIZGZYHOMD-UHFFFAOYSA-N Dioxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 claims description 17
- 229940057995 liquid paraffin Drugs 0.000 claims description 17
- 229910001882 dioxygen Inorganic materials 0.000 claims description 16
- 230000004087 circulation Effects 0.000 claims description 14
- 230000004907 flux Effects 0.000 claims description 14
- 239000000126 substance Substances 0.000 claims description 13
- 238000009987 spinning Methods 0.000 claims description 11
- 238000000605 extraction Methods 0.000 claims description 9
- 238000002156 mixing Methods 0.000 claims description 8
- 229920002545 silicone oil Polymers 0.000 claims description 8
- 238000002844 melting Methods 0.000 claims description 6
- 230000008018 melting Effects 0.000 claims description 6
- 230000015556 catabolic process Effects 0.000 claims description 5
- 238000002425 crystallisation Methods 0.000 claims description 5
- 230000008025 crystallization Effects 0.000 claims description 5
- 238000006731 degradation reaction Methods 0.000 claims description 5
- 238000007599 discharging Methods 0.000 claims description 5
- 229920001223 polyethylene glycol Polymers 0.000 claims description 5
- 239000011369 resultant mixture Substances 0.000 claims description 5
- 239000002202 Polyethylene glycol Substances 0.000 claims description 4
- 239000004698 Polyethylene Substances 0.000 claims 1
- 229920000573 polyethylene Polymers 0.000 claims 1
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 24
- 239000000203 mixture Substances 0.000 description 18
- 239000001569 carbon dioxide Substances 0.000 description 12
- 229910002092 carbon dioxide Inorganic materials 0.000 description 12
- 239000012530 fluid Substances 0.000 description 10
- 230000000694 effects Effects 0.000 description 9
- 238000012546 transfer Methods 0.000 description 9
- 238000010438 heat treatment Methods 0.000 description 8
- QQONPFPTGQHPMA-UHFFFAOYSA-N propylene Natural products CC=C QQONPFPTGQHPMA-UHFFFAOYSA-N 0.000 description 8
- 125000004805 propylene group Chemical group [H]C([H])([H])C([H])([*:1])C([H])([H])[*:2] 0.000 description 8
- 230000001747 exhibiting effect Effects 0.000 description 7
- 230000035699 permeability Effects 0.000 description 7
- 239000002994 raw material Substances 0.000 description 7
- 241000283690 Bos taurus Species 0.000 description 6
- 239000000945 filler Substances 0.000 description 6
- 238000012856 packing Methods 0.000 description 6
- 235000010356 sorbitol Nutrition 0.000 description 6
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 5
- 206010018910 Haemolysis Diseases 0.000 description 5
- 239000003570 air Substances 0.000 description 5
- 239000000306 component Substances 0.000 description 5
- 230000008588 hemolysis Effects 0.000 description 5
- 229920000098 polyolefin Polymers 0.000 description 5
- 238000004382 potting Methods 0.000 description 5
- 239000000600 sorbitol Substances 0.000 description 5
- AJDIZQLSFPQPEY-UHFFFAOYSA-N 1,1,2-Trichlorotrifluoroethane Chemical compound FC(F)(Cl)C(F)(Cl)Cl AJDIZQLSFPQPEY-UHFFFAOYSA-N 0.000 description 4
- 102000001554 Hemoglobins Human genes 0.000 description 4
- 108010054147 Hemoglobins Proteins 0.000 description 4
- 238000009826 distribution Methods 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 229920002379 silicone rubber Polymers 0.000 description 4
- 239000004945 silicone rubber Substances 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 239000013078 crystal Substances 0.000 description 3
- 150000008282 halocarbons Chemical class 0.000 description 3
- 229920001519 homopolymer Polymers 0.000 description 3
- 230000001939 inductive effect Effects 0.000 description 3
- 229920005989 resin Polymers 0.000 description 3
- 239000011347 resin Substances 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- 241000894007 species Species 0.000 description 3
- CBQYNPHHHJTCJS-UHFFFAOYSA-N Alline Chemical compound C1=CC=C2C3(O)CCN(C)C3NC2=C1 CBQYNPHHHJTCJS-UHFFFAOYSA-N 0.000 description 2
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 description 2
- 239000005977 Ethylene Substances 0.000 description 2
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- 239000000853 adhesive Substances 0.000 description 2
- WNLRTRBMVRJNCN-UHFFFAOYSA-N adipic acid Chemical compound OC(=O)CCCCC(O)=O WNLRTRBMVRJNCN-UHFFFAOYSA-N 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 230000002950 deficient Effects 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- 229930195733 hydrocarbon Natural products 0.000 description 2
- 150000002430 hydrocarbons Chemical class 0.000 description 2
- 239000000155 melt Substances 0.000 description 2
- 239000005026 oriented polypropylene Substances 0.000 description 2
- 239000012188 paraffin wax Substances 0.000 description 2
- 238000005191 phase separation Methods 0.000 description 2
- 238000007639 printing Methods 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- FMZUHGYZWYNSOA-VVBFYGJXSA-N (1r)-1-[(4r,4ar,8as)-2,6-diphenyl-4,4a,8,8a-tetrahydro-[1,3]dioxino[5,4-d][1,3]dioxin-4-yl]ethane-1,2-diol Chemical compound C([C@@H]1OC(O[C@@H]([C@@H]1O1)[C@H](O)CO)C=2C=CC=CC=2)OC1C1=CC=CC=C1 FMZUHGYZWYNSOA-VVBFYGJXSA-N 0.000 description 1
- UGCSPKPEHQEOSR-UHFFFAOYSA-N 1,1,2,2-tetrachloro-1,2-difluoroethane Chemical compound FC(Cl)(Cl)C(F)(Cl)Cl UGCSPKPEHQEOSR-UHFFFAOYSA-N 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical class CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 1
- AMQJEAYHLZJPGS-UHFFFAOYSA-N N-Pentanol Chemical class CCCCCO AMQJEAYHLZJPGS-UHFFFAOYSA-N 0.000 description 1
- 239000001361 adipic acid Substances 0.000 description 1
- 235000011037 adipic acid Nutrition 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 229910052786 argon Inorganic materials 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 239000012503 blood component Substances 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 230000000747 cardiac effect Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 230000006735 deficit Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 229940087101 dibenzylidene sorbitol Drugs 0.000 description 1
- UMNKXPULIDJLSU-UHFFFAOYSA-N dichlorofluoromethane Chemical compound FC(Cl)Cl UMNKXPULIDJLSU-UHFFFAOYSA-N 0.000 description 1
- 229940099364 dichlorofluoromethane Drugs 0.000 description 1
- 125000000118 dimethyl group Chemical group [H]C([H])([H])* 0.000 description 1
- LQZZUXJYWNFBMV-UHFFFAOYSA-N dodecan-1-ol Chemical compound CCCCCCCCCCCCO LQZZUXJYWNFBMV-UHFFFAOYSA-N 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 238000000635 electron micrograph Methods 0.000 description 1
- 239000003822 epoxy resin Substances 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 239000001307 helium Substances 0.000 description 1
- 229910052734 helium Inorganic materials 0.000 description 1
- SWQJXJOGLNCZEY-UHFFFAOYSA-N helium atom Chemical compound [He] SWQJXJOGLNCZEY-UHFFFAOYSA-N 0.000 description 1
- 238000005534 hematocrit Methods 0.000 description 1
- ZSIAUFGUXNUGDI-UHFFFAOYSA-N hexan-1-ol Chemical class CCCCCCO ZSIAUFGUXNUGDI-UHFFFAOYSA-N 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 238000002074 melt spinning Methods 0.000 description 1
- QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 description 1
- 229910052753 mercury Inorganic materials 0.000 description 1
- 238000001000 micrograph Methods 0.000 description 1
- 239000000178 monomer Substances 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- JCXJVPUVTGWSNB-UHFFFAOYSA-N nitrogen dioxide Inorganic materials O=[N]=O JCXJVPUVTGWSNB-UHFFFAOYSA-N 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- 238000005453 pelletization Methods 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 229920003216 poly(methylphenylsiloxane) Polymers 0.000 description 1
- 229920000647 polyepoxide Polymers 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical class CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 1
- 229920001384 propylene homopolymer Polymers 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000009877 rendering Methods 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 description 1
- 239000004299 sodium benzoate Substances 0.000 description 1
- 235000010234 sodium benzoate Nutrition 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 239000001488 sodium phosphate Substances 0.000 description 1
- 229910000162 sodium phosphate Inorganic materials 0.000 description 1
- 235000011008 sodium phosphates Nutrition 0.000 description 1
- 239000008279 sol Substances 0.000 description 1
- 238000007711 solidification Methods 0.000 description 1
- 230000008023 solidification Effects 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 235000012222 talc Nutrition 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
- 238000004804 winding Methods 0.000 description 1
Landscapes
- External Artificial Organs (AREA)
- Separation Using Semi-Permeable Membranes (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP8,982/1987 | 1987-01-20 | ||
| JP898287 | 1987-01-20 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA1310159C true CA1310159C (fr) | 1992-11-17 |
Family
ID=11707895
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA000556829A Expired - Lifetime CA1310159C (fr) | 1987-01-20 | 1988-01-19 | Membrane de fibres creuses de polypropylene poreux, methode pour sa production et son utilisation dans des poumons artificiels |
Country Status (1)
| Country | Link |
|---|---|
| CA (1) | CA1310159C (fr) |
-
1988
- 1988-01-19 CA CA000556829A patent/CA1310159C/fr not_active Expired - Lifetime
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0341309B1 (fr) | Membrane de polypropylene poreux et procede de production | |
| CA1271907A (fr) | Membrane de fibres creuses derivees de la filature d'une composition de polyolefine et de produit de charge en fusion | |
| EP0209465B1 (fr) | Membrane sous forme de fibre creuse pour poumon artificiel, son procédé de fabrication, et poumon artificiel utilisant cette fibre creuse | |
| US6375876B1 (en) | Method for producing an integrally asymmetrical polyolefin membrane | |
| JP4996011B2 (ja) | 一体型非対称ポリオレフィン膜 | |
| KR100991596B1 (ko) | 할라 막 | |
| US5489382A (en) | Oxygenator using porous hollow fiber membrane | |
| EP0217698A2 (fr) | Procédé de fabrication d'une membrane poreuse pour séparer des éléments du sang | |
| JPH0235918A (ja) | ポリプロピレン多孔質中空糸膜およびその製造方法 | |
| CA1310159C (fr) | Membrane de fibres creuses de polypropylene poreux, methode pour sa production et son utilisation dans des poumons artificiels | |
| CA1324470C (fr) | Membrane poreuse en fibres creuses, methode de production et oxygenateur forme de ce type de membrane | |
| JPS6297603A (ja) | ポリプロピレン多孔質膜およびその製造方法 | |
| JPH01168303A (ja) | 多孔質中空糸膜およびその製造方法ならびに人工肺 | |
| JPH01228505A (ja) | 多孔質中空糸膜、その製造方法およびその中空糸膜を用いた人工肺 | |
| JPH0474046B2 (fr) | ||
| JP2932189B2 (ja) | 多孔質中空糸膜および中空糸膜型人工肺 | |
| JPH0563212B2 (fr) | ||
| JPH01228503A (ja) | 多孔質中空糸膜、その製造方法およびその中空糸膜を用いた人工肺 | |
| JPH0542207A (ja) | 多孔質中空糸膜、人工肺および体外循環回路 | |
| JPS6190707A (ja) | 中空糸膜の製造方法 | |
| JPS63224702A (ja) | ポリプロピレン多孔質膜およびその製造方法 | |
| JPH0564663A (ja) | 多孔質中空糸膜および人工肺 | |
| JPH01228506A (ja) | 多孔質中空糸膜、その製造方法およびその中空糸膜を用いた人工肺 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MKEX | Expiry |